Research

Area 1

Systemic autoimmune diseases

Articles during the year 2015
Original

Published originals: 38

Impact factor: mean: 5.05, total: 191.76

  • Brain abnormalities in newly diagnosed neurophychiatric lupus: Systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort

    Sarbu N, Alobeidi F, Toledano P, Espinosa G, Giles I, Rahman A, Yousry T, Capurro S, Jäger R, Cervera R, Bargalló N
    Autoimmun Rev. 2015; 14(2): 153-159. IF: 7.933

  • Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever

    Beça S, Rodríguez-Pintó I, Alba MA, Cervera R, Espinosa G
    Autoimmun Rev. 2015; 14(7): 586-593. IF: 7.933

  • The European Registry of Obstetric Antiphospholipid Syndrome (EUROAPS) : A survey of 247 consecutive cases

    Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Coloma-Bazán E, de Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A, Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K, llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina I (EUROAPS Study Group Collaborators)
    Autoimmun Rev. 2015; 14(5): 387-395. IF: 7.933

  • Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell
    Arthritis Rheumatol. 2015; 67(7): 1837-1847. IF: 7.764

  • Predictors of long-term renal outcome in lupus nephritis trials Lessons learned from the Euro-Lupus Nephritis Cohort

    Dall’Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, Rovin BH, Mackay M
    Arthritis Rheumatol. 2015; 67(5): 1305-1313. IF: 7.764

Editorials

Published editorials: 3

Impact factor: mean: 2.28, total: 6.85

  • Sustained Remission: An Unmet Need in Patients with Giant-cell Arteritis

    Cid MC, Alba MA
    J Rheumatol. 2015; 42(7): 1081-1082. IF: 3.187

  • Etanercept and veitis: friends or foes?

    Brito-Zerón P, Perez-Alvarez R, Ramos-Casals M; BIOGEAS Study Group
    Curr Med Res Opin. 2015; 31(2): 251-252. IF: 2.653

More articles